By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome British Columbia has started a new Personalized Medicine Program, which includes financial support from the non-profit BC Cancer Foundation, by awarding an initial investment of around C$9 million ($9.4 million) in funding to three studies.

The new program seeks to use genomics research to tailor improved treatments for patients, to mitigate ineffective treatments and side effects, and to use genomic knowledge in disease prevention and early diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.